Clinical Trials Insight: 700031188
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2008
At a glance
- Drugs SEP 227162 (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- Sponsors Sunovion Pharmaceuticals
- 05 Mar 2008 New trial record.
- 01 Mar 2008 The trial is expected to be initiated in quarter 2 of 2008.